26 June 2024
26 June 2024
The ReCET System is designed to improve outcomes for individuals with type 2 diabetes.
In a time of profound global geopolitical instability, cyberattacks have become as much about mass disruption than monetary gain.
A 13-year-old patient with Lennox-Gastaut syndrome has seen an 80% reduction in daytime seizures since using the Picostim DyNeuMo system.
The eCART software can continuously assess hospitalised patients' risk of impending death or ICU transfer.
The first ever in human procedure with the device saw a patient treated five times to address their multifocal epilepsy.
A real-world study found that 92% of patients reported pain improvement over 18 months upon using FDA-approved NXTSTIM’s EcoAI device.
The Clarius OB AI model can perform biometry measurements to estimate foetal weight, age, and growth intervals.
Designed to treat stress urinary incontinence, the UroActive implant can be placed around the urethral duct.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
